Lonza expands in Asia: 8000L single-use in Singapore, regenerative meds in Japan – BioPharma-Reporter.com
BioPharma-Reporter.com |
Lonza expands in Asia: 8000L single-use in Singapore, regenerative meds in Japan
BioPharma-Reporter.com The firm recently acquired European cell and gene therapy maker PharmaCell in a deal that a spokesperson told this publication places Lonza as the “leading contract development and manufacturing organisation offering an international cell and gene … |
